Editorials:

John C. Somberg

The Direction of the ACCP
J Clin Pharmacol 1993 33: 199. [PDF]  

Articles:

GD Solomon

Therapeutic advances in migraine
J Clin Pharmacol 1993 33: 200. [Abstract] [PDF]  

JT Wilson

Pediatric pharmacology: the path clears for a noble mission
J Clin Pharmacol 1993 33: 210. [Abstract] [PDF]  

S Kacew

Adverse effects of drugs and chemicals in breast milk on the nursing infant
J Clin Pharmacol 1993 33: 213. [Abstract] [PDF]  

K Ohashi, T Sudo, K Sakamoto, T Tateishi, A Fujimura, Y Kumagai, and A Ebihara

The influence of pretreatment periods with diltiazem on nifedipine kinetics
J Clin Pharmacol 1993 33: 222. [Abstract] [PDF]  

G Ghirlanda, A Oradei, A Manto, S Lippa, L Uccioli, S Caputo, AV Greco, and GP Littarru

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study
J Clin Pharmacol 1993 33: 226. [Abstract] [PDF]  

A Ohnishi, Y Ko, H Fujihara, G Miyamoto, K Okada, and M Odomi

Pharmacokinetics, safety, and pharmacologic effects of OPC-21268, a nonpeptide orally active vasopressin V1 receptor antagonist, in humans
J Clin Pharmacol 1993 33: 230. [Abstract] [PDF]  

LA Jaber, NJ Lewis, RL Slaughter, and AV Neale

The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy
J Clin Pharmacol 1993 33: 239. [Abstract] [PDF]  

TR Browne, GK Szabo, A Ajami, and D Wagner

Performance of human mass balance/metabolite identification studies using stable isotope (13C, 15N) labeling and continuous-flow isotope-ratio mass spectrometry as an alternative to radioactive labeling methods
J Clin Pharmacol 1993 33: 246. [Abstract] [PDF]  

SF Cavanah, JM Jacobson, and T McIntyre

Clinical use of androgenic steroids at a major medical center: who prescribes androgens and how well do they do it?
J Clin Pharmacol 1993 33: 253. [Abstract] [PDF]  

SG Carruthers

The place of alpha blockers in the antihypertensive armamentarium
J Clin Pharmacol 1993 33: 260. [Abstract] [PDF]  

MC Houston

Alpha blockers: an effective extension to your patients' risk reduction program
J Clin Pharmacol 1993 33: 264. [Abstract] [PDF]  

J Cohen

Long-term efficacy and safety of terazosin
J Clin Pharmacol 1993 33: 272. [PDF]  

J Somberg, S Ehrenpreis, G Shroff, and S Khosla

Risk factors not addressed in antihypertensive therapy based solely on blood pressure control
J Clin Pharmacol 1993 33: 279. [Abstract] [PDF]  

SW Rabkin

Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment
J Clin Pharmacol 1993 33: 286. [Abstract] [PDF]  

Alpha Blockade Symposium:

John C. Somberg

A Symposium on Alpha Blockade
J Clin Pharmacol 1993 33: 259. [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.